title: Stability of extemporaneously prepared sodium phenylbutyrate oral suspensions.
abstract: OBJECTIVE
  In an effort to minimize barriers to compliance and adherence and to improve the accuracy of dosage measurement, sugar-containing and sugar-free sodium phenylbutyrate suspensions were formulated, and the stability of these products over a 90-day period was determined.
  
  
  METHODS
  An oral suspension of sodium phenylbutyrate 200 mg/mL was prepared by thoroughly grinding 12 g of Sodium Phenylbutyrate Powder, USP, in a glass mortar. Thirty milliliters of Ora-Plus and 30 mL of either Ora-Sweet or Ora-Sweet SF were mixed and added to the powder to make a final volume of 60 mL. Three identical samples of each formulation were prepared and placed in 2-oz amber plastic bottles with child-resistant caps and were stored at room temperature. A 500-microL sample was withdrawn from each of the six bottles with a micropipette immediately after preparation and at 7, 14, 28, 60, and 90 days. After further dilution to an expected concentration of 100 microg/mL with the mobile phase, the samples were assayed by high-performance liquid chromatography. Stability was defined as the retention of at least 90% of the initial concentration.
  
  
  RESULTS
  At least 95% of the initial sodium phenylbutyrate concentration remained throughout the 90-day study period in both preparations. There were no detectable changes in color, odor, taste, and pH and no visible microbial growth in any sample.
  
  
  CONCLUSIONS
  Extemporaneously compounded suspensions of sodium phenylbutyrate, 200 mg/mL, in a 1:1 mixture of Ora-Plus and Ora-Sweet or Ora-Sweet SF were stable for at least 90 days when stored in 2-oz amber plastic bottles at room temperature.
authors.affiliation: Pediatric Cardiothoracic Unit, University of Michigan Hospitals and Health Centers, Ann Arbor, MI 48109-0008, USA. rcaruthe@med.umich.edu
authors.forename: Regine L
authors.initials: RL
authors.lastname: Caruthers
authors.forename: Cary E
authors.initials: CE
authors.lastname: Johnson
mesh_terms: D000284:Administration, Oral; D004339:Drug Compounding / Q000379:methods / Q000592:standards*; D004355:Drug Stability; D004356:Drug Storage / Q000379:methods / Q000592:standards; D010654:Phenylbutyrates / Q000737:chemistry* / Q000592:standards*; D013535:Suspensions
chemical_list: D010654:Phenylbutyrates; D013535:Suspensions; C075773:4-phenylbutyric acid